IDEAYA Biosciences, Inc. 7,619,048 Shares of Common Stock Underwriting AgreementUnderwriting Agreement • September 19th, 2022 • IDEAYA Biosciences, Inc. • Pharmaceutical preparations • New York
Contract Type FiledSeptember 19th, 2022 Company Industry JurisdictionIDEAYA Biosciences, Inc., a Delaware corporation (the “Company”), proposes to issue and sell to the several underwriters listed in Schedule 1 hereto (the “Underwriters”), for whom you are acting as representatives (the “Representatives”), an aggregate of 7,619,048 shares of common stock, par value $0.0001 per share (“Common Stock”), of the Company (the “Underwritten Shares”). In addition, the Company proposes to issue and sell, at the option of the Underwriters, up to an additional 1,142,857 shares of Common Stock of the Company (the “Option Shares”). The Underwritten Shares and the Option Shares are herein referred to as the “Shares.” The shares of Common Stock of the Company to be outstanding after giving effect to the sale of the Shares are referred to herein as the “Stock.”